Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.
about
Exploiting tumor epigenetics to improve oncolytic virotherapyInduction of the interferon response by siRNA is cell type- and duplex length-dependentImmune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cellsRecombinant Newcastle disease virus as a vaccine vector for cancer therapyVesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivoEngineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinomaPotentiating cancer immunotherapy using an oncolytic virusNewcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell deathViral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-AntagonistsOncolytic viruses: finally deliveringDendritic Cells in Oncolytic Virus-Based Anti-Cancer TherapyPotential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus VariantsFrom scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancerGenetic, immunological, and pharmacological strategies to generate improved oncolytic virusesThe ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implicationsOncolytic virus therapy for glioblastoma multiforme: concepts and candidatesVesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerTrial Watch:: Oncolytic viruses for cancer therapyUnderstanding and altering cell tropism of vesicular stomatitis virusTrial Watch-Oncolytic viruses and cancer therapyOncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancerMechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapyChikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the BrainAvian Paramyxovirus: A Brief ReviewInterferon-induced tetherin restricts vesicular stomatitis virus release in neuronsTargeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virusCombined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infectionSerotype-Specific Killing of Large Cell Carcinoma Cells by Reovirus.Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude mice.A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers.Activation of an antiviral response in normal but not transformed mouse cells: a new determinant of minute virus of mice oncotropismPotential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer.Explicit targeting of transformed cells by VSV in ovarian epithelial tumor-bearing Wv mouse modelsVesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production.Evaluation of an attenuated vesicular stomatitis virus vector expressing interferon-beta for use in malignant pleural mesothelioma: heterogeneity in interferon responsiveness defines potential efficacy.Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors.Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential.Recombinant oncolytic poliovirus eliminates glioma in vivo without genetic adaptation to a pathogenic phenotype.Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.
P2860
Q21131237-37038EEB-AAB5-48C7-A328-6DFE8A4D34AFQ24544339-4E08009D-FD15-4A67-8204-7A557ABDAA4EQ24596171-A7FAA40E-DC19-4436-8AA0-5C0414B12A1EQ24602706-04EEBD58-C94F-4C7F-83E7-7EB35D518DF6Q24602728-664474BB-F21C-4A7B-A55E-D3FACB2E1690Q24625780-BB8A11ED-7C7B-4B3A-B4E2-8D4DA5A5D87CQ24628144-2EDC02DE-F050-4FC2-B9E8-243C396A692BQ24628810-4FAD7D38-161D-440D-AE01-DA0D150C1EA1Q24674186-5EE0C402-1589-4908-AEC5-43662E45BE47Q26745547-888E08CE-1CDD-4199-98A9-D0F5113D18F4Q26772039-3240EEB4-AC7E-45D0-83AE-1BECAAE50254Q26774345-FCB9C26B-02B7-49A6-9B27-B002AAB49A41Q26775033-256CA274-3993-4B47-AEE5-344C86C01B66Q26822694-1A31F59D-2BBD-4EEE-9E88-7B4B09A2335BQ26859879-9857C786-588D-474A-9B45-A8CE94922653Q27002660-A55343F4-6DA8-46E7-A2CE-2472EE7C8C1BQ27007519-977B9C8A-537F-4859-A2A8-48E4875B4522Q27021839-49FA363D-4E5E-4A2C-A373-42254EA818D5Q27021951-8F44B456-9ED0-41B4-BC70-165E7E00AE34Q27687067-B26198D1-DE04-454B-A0A4-084B61E35F7AQ28072347-4CEEC376-E1F3-412B-B575-83790839DC32Q28078939-F2F4B7A8-F75F-4203-9417-5532C3B40940Q28083766-AED70418-AB4C-4B7E-8BF4-13A5845131F1Q28223031-75563265-7412-437E-AB74-2051C00B085CQ28261383-964AE4D7-D145-46EC-A914-47242183A40AQ28585561-4373CBA7-3818-424C-BD7F-1C405ED8199CQ28755816-446D03C2-6A5B-480F-B849-BE1D7A6867A7Q28817152-2E94B565-624F-458A-9CA9-FFEDCDE6EFA6Q32183285-E1F08472-925F-4647-BFCE-35FF602C2102Q33523284-A18E6635-28F7-4CA5-B4DD-12A2F0F70026Q33554262-53558117-3C0E-4F95-806A-91AE090B9D00Q33558702-3704C8AE-2F27-47B6-9497-AA254AB1C2A0Q33579385-B93F8F07-304C-4BF1-98DD-0D68B7E64891Q33620680-653DD52C-70DB-4A98-A75D-7B1B79C9F407Q33667768-08B1CFBA-B1FE-470E-92D5-F0D7EF7725ECQ33691838-A6CA7486-2CF0-412F-8ACC-B5509E376C3CQ33750535-B6F60A80-9903-4B67-BBED-5394D1581201Q33780536-DD90F845-5679-44AF-8F15-615C67D39B2CQ33797119-1A7570DD-D38D-4F2E-B8C5-594B27754A9EQ33806399-818AE4A2-16A3-4A95-BC17-969592157FCF
P2860
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Exploiting tumor-specific defe ...... ously unknown oncolytic virus.
@ast
Exploiting tumor-specific defe ...... ously unknown oncolytic virus.
@en
type
label
Exploiting tumor-specific defe ...... ously unknown oncolytic virus.
@ast
Exploiting tumor-specific defe ...... ously unknown oncolytic virus.
@en
prefLabel
Exploiting tumor-specific defe ...... ously unknown oncolytic virus.
@ast
Exploiting tumor-specific defe ...... ously unknown oncolytic virus.
@en
P2093
P356
P1433
P1476
Exploiting tumor-specific defe ...... ously unknown oncolytic virus.
@en
P2093
Sonenberg N
P2888
P304
P356
10.1038/77558
P407
P577
2000-07-01T00:00:00Z
P5875
P6179
1026483107